AAPG – ascentage pharma group international - american depository shares (US:NASDAQ)
Stock Stats
News
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
Ascentage Pharma Group International (AAPG) was upgraded by BTIG Research to "strong-buy".
Ascentage Pharma Group International (AAPG) had its "buy" rating reaffirmed by BTIG Research. They now have a $48.00 price target on the stock.
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.